Incubation of Haemophilus influenzae type b at -107 CFU/ml with serum ultrafiltrate induces a phenotypic conversion in which complement-mediated bactericidal activity by somatic antibodies decreases while killing by capsular antibody is unchanged. Conversion had been shown to occur in a capsule-deficient (b-) mutant of strain Eag (thus appearing independent of capsulation), to include an increase in lipopolysaccharide content, and to be inhibited by chloramphenicol or puromycin. In the present study, in several strains not previously examined, conversion was not inhibited by the drugs and the corresponding b-mutants did not convert. Incubation in ultrafiltrate was also found to increase capsulation, as detected by radioassay, only 1.6-fold in Eag but 4.5-fold in DL26, the strain with the largest increase in resistance; moreover, complement-mediated opsonization by capsular antibody was greatly decreased. Thus, multiple mechanisms, capsule dependent as well as independent, appear to contribute to the serum factor-induced resistance of H. influenzae type b to antibody.
Haemophilus influenzae type b (Hib), like other gramnegative bacteria, can be killed by bactericidal (BC) antibody and complement in vitro. Hib from the blood of infected rats was more resistant to BC activity than the same strain grown in conventional broth. By incubation at 37°C and <107 CFU/ml with a 500-molecular-weight filtrate of normal serum, broth-grown Hib was converted within 30 min to a resistant phenotype resembling that of in vivo organisms (23) . Some degree of this phenotypic conversion has been found in all of nine tested Hib strains (3, 13, 15) . The structural basis of the difference between broth-grown (Sen) and resistant (Res) bacteria is difficult to study because of the limited yields of Res bacteria. The resistance affects killing by antibodies to lipopolysaccharide (LPS) and some outer membrane proteins (OMPs) (16) , while Res and Sen cells are equally susceptible to the BC activity of capsular antibody (3, 16, 23) . In six of six studied strains, cells with the Res phenotype appeared to contain two-to fourfold more LPS of the same electrophoretic mobility as that of the LPS from cells with the Sen phenotype. In the strain (Eag) studied in most detail, chloramphenicol or puromycin, which blocked the increase in resistance, also blocked the apparent increase in LPS content. Sen and Res cells of strain Eag produced roughly equal amounts of the polyribosyl-ribitolphosphate capsular antigen (PRP) per CFU (13, 23) . Moreover, a capsule-deficient (b-) mutant, strain Eag b-S2, although much more sensitive to LPS antibody, responded to serum filtrate with a relative increase in resistance similar to the parent strain. Therefore, it appeared that the phenotypic conversion was independent of capsule expression (13, 23) .
In the present study, when additional strains were examined, several were found in which conversion was not blocked by chloramphenicol or puromycin and was not expressed in the b-mutants. This observation led to reexamination of capsule expression, and it was found that Res cells expressed more PRP per unit of cell protein than Sen cells. Additional evidence for an increase in functional capsulation was found in the effect of the shift on uptake by leukocytes in vitro. Res cells were more resistant to opsonization not only by antibodies to somatic antigens but also by antibodies to PRP. Overall the data indicate that at least two mechanisms are involved in the acquisition of resistance in response to low-molecular-weight components of serum.
MATERIALS AND METHODS
Bacterial strains. Hib strains Eag, Rab, and Mad (3), DL26 (9) , and DL42, DL63, and OA104 (7) have been described. Hib strains Eag b-S2 (2) and DL26 b-#1 (9) are spontaneous capsule-deficient (b-) mutants that appear as colonies smaller and less mucoid than those of their parents; these mutants were shown to elaborate <1% of the parental amount of PRP but to express the same OMP (9, 18) and LPS (9, 11) immediately or after further incubation in PCMA for 30 min at 37°C; both preparations are equally susceptible to BC activity (13) . To make Res bacteria, bacteria at 5 x 106 CFU/ml in PCMA were mixed 1:1 with serum filtrate and incubated for 30 min at 37°C. Adjustments were made for the somewhat larger increase in CFU in the serum filtrate. The effect of chloramphenicol (0.01 to 0.06 mM) or puromycin (0.02 mM) on conversion was tested by adding the drugs at the onset of the 30-min incubation; the concentration of antibiotics used was capable of inhibiting the growth of each strain in control studies. Assays to compare phenotypes were done after either washing or diluting 300-fold in PCMA so the test environments were equal. Biological reagents. The precolostral calf serum used as the complement source and the filtrate of normal human serum (PM10 filter, 10,000-molecular-weight cutoff; Amicon Corp., Danvers, Mass.) were described previously (13) . Preparation of rabbit antiserum to purified LPS of strain Eag (RT214) and to live Eag b-S2 in the Res phenotype (RT212) was also described previously (13) ; Western blot (immunoblot) analysis later showed a majority of antibodies reactive with the characteristic LPS band but also antibodies reactive with OMPs or possibly traces of LPS bound to these proteins (16) . RT212 killed all strains in the study except Mad and OA104, and RT214 killed all but Mad. Rabbit antiserum R17 was raised against whole cells of strain Mad b-; it killed Mad as well as Mad b-. In the antisera described above at the dilutions used, the concentrations of capsular (PRP) antibodies were undetectable (<0.04 ,g/ml) in the radioassay described below. Affinity column-purified rabbit antiserum against Eag LPS was the gift of Marilyn Loeb, and immunoglobulin G (IgG) from human donors vaccinated with various bacterial polysaccharides including that of Hib (BPIG) was the gift of George Siber (1). Monoclonal antibodies (MAbs) to Hib LPS (6A2 and 5G8, murine IgG) (8) and to PRP (16M3C8, human IgG) (6) were previously described. MAbs 6A2 and 5G8, which were produced in tissue culture, were dialyzed twice at 4°C overnight with 200 volumes of PCM (similar to PCMA but without albumin) to avoid the possible BC effect of antibiotics present in the culture supernatant. MAb 16M3C8, from mouse ascites, was partially purified by ammonium sulfate fractionation and dialysis.
BC assay. Duplicate mixtures of the bacteria (4 x 104 CFU/ml), the complement source (see below for dilutions), and serial dilutions of antiserum were brought to total volumes of 30 [lI with PCMA in 96-well microtiter plates.
The mixtures were incubated for 30 min at 37°C and chilled to stop the BC reaction. Samples (10 ,ul) were spread on BHI-XV agar, and the number of colonies after 24 h of incubation at 37°C was counted to determine the percent survival [100 x (CFU after incubation with antiserum/CFU after incubation without antiserum)]. The mean percent survival values were graphed to estimate the dilution of antibody giving 50% survival (D50), and the shift ratio was computed as D50 of Res bacteria/D50 of Sen bacteria. Every strain was preliminarily tested in a checkerboard titration in which both antibody source and complement were independently diluted; thus, a plateau range of complement concentrations was defined that caused no killing per se but supported antibody-dependent killing. The capsulated strains were not killed by complement at the highest concentration tested (33% [vol/vol]); 10% (vollvol) complement fell on the plateau and was used in the BC assay for these strains. The b-mutants were killed to some degree by complement at higher concentrations, but 2.5% (vol/vol) could be used as a plateau concentration for these strains.
Radioantigen binding inhibition assay for PRP content. Bacteria of the Sen and Res phenotypes were centrifuged at 12,000 x g for 15 min, washed once with PCM, and resuspended in a known volume of PCM at an estimated 108 CFU/ml. Small samples of the bacterial suspensions were diluted in PCM and plated onto BHI-XV agar to determine the actual CFU. The bulk of the bacteria were then centrifuged, the supernatants were discarded, and the bacterial pellets were kept at -70°C. After the number of CFU was determined (the following day), the bacterial pellets were suspended with distilled water to an equivalent of --1.8 x 109 CFU/ml and samples of the suspensions were assayed for protein by the version of the method of Lowry et al. intended for insoluble proteins (19 (2), and the amount of nonradioactive PRP active as an inhibitor in the bacterial suspensions was determined from a standard inhibition curve made with twofold dilutions of purified PRP (4) at 400 to 3.125 ng/ml in place of bacterial cells.
Quantitation of LPS by electrophoresis. The apparent content of LPS in the bacteria was examined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (17) and periodate-silver staining (28) . The bacteria were collected, washed, resuspended, and adjusted to the same protein concentration as described above. Twenty-five microliters of each bacterial suspension in distilled water (containing about 3.9 ,ug of protein) was mixed with 25 ,ul of 2 x cracking buffer, and the mixture was heated for 5 min at 100°C. The mixture was then combined with 10 RI of proteinase K (2.5 mg/ml in water) and incubated at 60°C for 1 h to digest the cell protein as described previously (27) .
Samples (40 RI) containing 2.6 pg of protein were electrophoresed in a 14% separating gel containing 3 M urea by using the discontinuous system of Laemmli (17) and stained by the periodate-silver method (28) . If actual CFU, and appropriate dilutions were tested in BC assays to verify the phenotype.
The opsonization of bacteria was done by mixing 5 ,ul of the bacterial suspension (containing -1.5 x 107 CFU) with 5 ,ul of complement source (at a suitable dilution in PCM depending on the bacterial strain) and 5 R1 of antibody source (at a specified dilution in PCM), incubating the mixtures for 20 min at 37°C, and then cooling them to 20°C in a water bath. PCM was also substituted for the complement source (for opsonization by antibody alone), antibody source (for opsonization by complement alone), or both (no opsonization).
Uptake by PMN was assayed by adding 10 p.1 of the opsonization mixtures (containing -107 CFU of bacteria) to 10 pL. of PMN suspension in a 15-ml polypropylene centrifuge tube and incubating for 15 min at 37°C with vigorous shaking. Ten milliliters of PCMA was added, and the PMN were sedimented by centrifugation at 125 x g for 10 min and washed once with 10 ml of PCM. The supernatant was removed, and the precipitate was dissolved with 0.3 ml of Protosol (Dupont, NEN) and added to 10 ml of toluene scintillant fluid (2) for determination of radioactivity. Percent uptake by the PMN in each sample was calculated by comparison with the total radioactive input. One set of incubations ( Fig. 3 and 4 , controls) was done with 3H-bacteria, but no PMN, to detect sedimentation of bacteria and/or sticking of radioactivity to the tubes; such radioactivity amounted to <2% of the total.
RESULTS
When examined with sources of polyclonal somatic antibody such as RT212 and RT214, strain DL26 showed a much greater increase in resistance than strains previously described (15; Table 1 ); therefore, the specificity of its phenotypic conversion was further examined. The effect of serum filtrate on killing of strain DL26 in the BC assay is shown in Fig. 1 . Conversion to resistance to a particular antibody source is given as the shift ratio: the fold increase in antibody required for 50% killing with a constant dilution of complement. For strain DL26 the shift ratio was 6.0 with a LPSdirected MAb but 1.0 with a PRP-directed MAb. Thus, as with previously studied strains, the difference between Sen and Res phenotypes was "recognized" by somatic but not capsular antibodies in the BC assay. Likewise, DL26 showed an apparent increase in LPS: Sen bacteria assayed directly from broth culture and Sen bacteria incubated in buffer had bands of equal density in SDS-PAGE, while Res bacteria showed bands about 1.5-fold denser in samples equalized for bacterial protein (Fig. 2A) . Very similar results were found under these conditions with strain Eag (Fig. 2B) , for which earlier studies had correlated periodate-silverstained band density with LPS concentration in an immunoassay (13 (Fig. 3) showed modest uptake without opsonization, and there was greater uptake of bacteria of the Sen (10%) than Res (6%) phenotype (P < 0.05). Uptake was not increased by exposure to complement alone. There was clear opsonization by the LPS MAb 6A2 plus complement, and uptake of bacteria of the Sen phenotype was increased substantially more than that of Res bacteria (P < 0.01). The strongest observed opsonization was by a PRP MAb plus complement; notably, Sen bacteria were more effectively opsonized than Res bacteria. In strain Eag (Fig. 4) by somatic antibodies, but the present study indicates that a single mechanism is unlikely to account for all the resistance in all strains. As a working hypothesis we envision at least two mechanisms: (i) one mechanism is inhibited by chloramphenicol or puromycin, can occur in b-mutants, gives at most a modest increase in resistance, and is accompanied by an apparent increase in LPS content; (ii) the other mechanism is insensitive to the inhibitors, does not occur in bmutants, can give large increases in resistance, and is accompanied by an increase in PRP that may be its structural basis. The resistance of particular strains to bacteriolysis can come from various combinations of mechanisms i and ii. For example, the capsule-deficient mutant Eag b-S2 acquires resistance entirely by mechanism i, while its parent may employ mechanism i but get a small increment of resistance also from mechanism ii. Strain DL26 gets a large increase in resistance by mechanism ii; since its b-mutants did not convert, it is possible that mechanism i contributes no resistance to the mutants or parent. (13) . If correct, this model might also account for the subsequently observed resistance to antibodies against certain outer membrane proteins (16) . However, strains DL26 ( Fig. 2A) and Rab (13) show the LPS increase while appearing to gain no resistance by mechanism i (Table  1) ; thus, additional LPS does not necessarily give greater resistance. Additional work is needed on the composition and steric relationships of membrane components in response to serum filtrate. The present finding of strains that appear not to gain resistance by mechanism i will assist future analysis. Such research would better be done with bmutants since the present study also shows ( Table 2 ) that incubation of capsulated Hib in serum filtrate can superpose a capsule increase upon hypothetical mechanism i.
It seems likely that the observed increase in capsule is the structural basis for mechanism ii. In gram-negative bacteria generally (26) and Hib in particular (12, 13, 29, 30) , it is known that genetic or phenotypic increases in capsulation can reduce the BC activity of somatic antibodies. The increase in PRP content brought about by serum filtrate was missed in two earlier studies (13, 23) . These studies compared Sen and Res bacteria on the basis of CFU rather than cell protein and also examined only strain Eag, which the present study showed to have a small, although consistent, increase. Eag is relatively highly capsulated even in Sen cells, so its 1.6-fold increase in conversion to Res may account for the very modest chloramphenicol-insensitive component of resistance to BC activity. At the other extreme, DL26 has low capsulation in Sen cells but had a large relative increase in response to serum filtrate, which may account for its large shift ratio.
For both strains, additional evidence that the increase in PRP (as determined by radioassay) increases capsulation in a functional sense was seen in the opsonization assay, in which the activity of capsular, as well as somatic, antibodies was diminished. It is an interesting but instructive paradox that the shift decreased the complement-dependent opsonization by PRP antibody but not the complement-dependent killing. In complement-mediated killing of gram-negative bacteria, it is thought that antibody must initiate the formation of the C5b-9 complex near the outer membrane (14) . Thus, in Hib, access of antibody to PRP epitopes proximal to the outer membrane evidently is not affected by the serum factor-induced increase in PRP content. Why the PRP increase diminishes the functional access of LPS and other somatic antibodies remains to be explained. The difference may be related to the observation that the BC activity of somatic antibodies against Hib requires classical pathway components (24) while killing by PRP antibody can utilize either classical or alternative pathways of complement activation (24, 25) . For best opsonization, the antibody-bound C3 must be activated in a site accessible to phagocytic cell receptors and protected from degradation by serum factors H and I (14) . Evidently in Res Hib, although more PRP antibody is bound than in Sen Hib, the site or mode of the subsequent complement activation is less effective.
Although serum BC activity in vitro is an accepted correlate of immunity to Hib (for a review, see reference 1), there (10) , in which presumably a Res-like phenotype pertains. Future animal challenge studies of antibody protectiveness might appropriately use Hib preconverted to the Res phenotype rather than the usual broth cultures grown to high density.
It appears that low-molecular-weight factor(s) able to produce the Res phenotype are present in the nasopharynx (15, 22) , the usual habitat of Hib. Thus, although the present study examined mechanisms of phenotypic conversion by these host factor(s), their actual role may be the maintenance of a Res-like phenotype in a bacterium that normally resides only in the human host.
